We are live on ! Find out more
VTVT icon

vTv Therapeutics
VTVT

39 hedge funds and large institutions have $18M invested in vTv Therapeutics in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 12

0% more ownership

Funds ownership: 0.93% → 0.94% (+0%)

5% less funds holding

Funds holding: 41 → 39 (-2)

24% less capital invested

Capital invested by funds: $23.7M → $18M (-$5.7M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
39
Holders Change
-2
Holders Change %
-4.88%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
13
Reduced
12
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$531K
2
SG Americas Securities
SG Americas Securities
New York
+$66.9K
3
Millennium Management
Millennium Management
New York
+$64K
4
Deutsche Bank
Deutsche Bank
Germany
+$59.4K
5
Renaissance Technologies
Renaissance Technologies
New York
+$52.5K

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$280K
2
GCP
GSA Capital Partners
United Kingdom
-$216K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$181K
4
BlackRock
BlackRock
New York
-$39.4K
5
JP Morgan Chase
JP Morgan Chase
New York
-$35K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
26
American International Group
New York
$22K -$1.67K -8 -7%
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$21K – – –
TRCT
28
Tower Research Capital (TRC)
New York
$8K +$3.54K +17 +68%
Manulife (Manufacturers Life Insurance)
29
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$7K +$625 +3 +9%
Barclays
30
Barclays
United Kingdom
$5K +$3.96K +19 +475%
BNP Paribas Financial Markets
31
BNP Paribas Financial Markets
France
$4.69K +$4.17K +20 +500%
Legal & General Group
32
Legal & General Group
United Kingdom
$4K – – –
MAM
33
Meeder Asset Management
Ohio
$4K – – –
Wells Fargo
34
Wells Fargo
California
$4K – – –
AG
35
Advisor Group
Arizona
$4K +$2.08K +10 +100%
Bank of America
36
Bank of America
North Carolina
$2K -$5.42K -26 -76%
AIP
37
Ameritas Investment Partners
Nebraska
$2K – – –
UBS Group
38
UBS Group
Switzerland
$1K +$417 +2 +33%
GCP
39
GSA Capital Partners
United Kingdom
– -$216K -824 Closed
JP Morgan Chase
40
JP Morgan Chase
New York
– -$35K -135 Closed
FPF
41
FNY Partners Fund
New York
– -$7K -31 Closed
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
– -$1.25K -6 Closed
Citigroup
43
Citigroup
New York
– -$417 -2 -50%
1
2

VTVT Hedge Fund Activity: Q2 2017 in Review

39 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q2 2017, worth a combined $18M — down 24% from $23.7M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of VTVT and 2 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 13 added.

The largest buyer was Ameriprise, adding an estimated $531K. The largest seller was Franklin Resources, cutting an estimated $280K.

  • 39 institutional investors held vTv Therapeutics (VTVT) as of Q2 2017, down from 41 in Q1 2017.
  • Funds reported $18M of vTv Therapeutics stock for Q2 2017, down 24% quarter-over-quarter.
  • 2 funds opened new vTv Therapeutics positions in Q2 2017 and 4 closed out, a net change of -2 holders.
  • The largest vTv Therapeutics buyer in Q2 2017 was Ameriprise, an estimated $531K added.
  • The largest vTv Therapeutics seller in Q2 2017 was Franklin Resources, an estimated $280K sold.

Based on aggregated 13F filings for Q2 2017.